Kopran Limited — Clarithromycin Exporter Profile
Indian Pharmaceutical Exporter · #14 for Clarithromycin · $888.1K export value · DGFT Verified
Kopran Limited is the #14 Indian exporter of Clarithromycin with $888.1K in export value and 21 verified shipments. Kopran Limited holds a 0.9% market share in Clarithromycin exports across 7 countries. The company exports 6 pharmaceutical products worth $7.3M across 5 therapeutic categories.
Kopran Limited — Clarithromycin Export Profile: Buyers & Destinations
Where Does Kopran Limited Export Clarithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CHILE | $112.9K | 8 | 26.4% |
| SUDAN | $100.0K | 2 | 23.3% |
| ETHIOPIA | $59.6K | 4 | 13.9% |
| MOZAMBIQUE | $50.0K | 1 | 11.7% |
| TANZANIA | $41.2K | 2 | 9.6% |
| CAMBODIA | $39.2K | 3 | 9.1% |
| SOUTH AFRICA | $25.6K | 1 | 6.0% |
Kopran Limited exports Clarithromycin to 7 countries. The largest destination is CHILE accounting for 26.4% of Kopran Limited's Clarithromycin shipments, followed by SUDAN (23.3%) and ETHIOPIA (13.9%). These destinations reflect Kopran Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Clarithromycin from Kopran Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | MOZAMBIQUE | $293.3K | 15 |
| OREDER OF HIBRET BANK | ETHIOPIA | $59.6K | 4 |
| TO THE ORDER | SUDAN | $50.0K | 1 |
| AUSTELL PHARMACEUTICALS (PTY) LTD | SOUTH AFRICA | $25.6K | 1 |
Kopran Limited supplies Clarithromycin to 4 buyers globally. The largest buyer is TO THE ORDER OF (MOZAMBIQUE), followed by OREDER OF HIBRET BANK (ETHIOPIA) and TO THE ORDER (SUDAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Clarithromycin Export Value and How Much Does Kopran Limited Contribute?
India exported $61.2M worth of Clarithromycin through 3,576 shipments from 334 suppliers to 144 countries, serving 811 buyers globally. Kopran Limited contributes $888.1K to this total, accounting for 0.9% of India's Clarithromycin exports. Kopran Limited ships Clarithromycin to 7 countries through 4 buyers.
What Is the Average Shipment Value for Kopran Limited's Clarithromycin Exports?
Kopran Limited's average Clarithromycin shipment value is $42.3K per consignment, based on 21 shipments totaling $888.1K. The largest destination is CHILE (26.4% of Kopran Limited's Clarithromycin exports).
How Does Kopran Limited Compare to Other Indian Clarithromycin Exporters?
Kopran Limited ranks #14 among 334 Indian Clarithromycin exporters with a 0.9% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($15.4M), MICRO LABS LIMITED ($15.4M), AUROBINDO PHARMA LTD ($7.8M). Kopran Limited processed 21 shipments to 7 destination countries.
What Clarithromycin Formulations Does Kopran Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSCLARITHROMYCINA 500 MG TABLETS (EACH TABLET CONTAINES CLARITHROMYCIN 500 MG) | $112.9K | 4 |
| HARMLESS MEDICINE PHARMACEUTICAL GOODSLOKIT HP COMBIPACK OF CLARITHROMYCIN250MG TABLETS OMEPRAZOLE 20MG CAPSULES | $50.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS CLARIMIN 500 MG TABLETS 5914 PACKS OF 10X10 TABS EACH (CLARITHROMYCIN 500 MG TABL | $50.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS LOKIT HP CAPSULES 76428 PACKS OF 7X6 CAPSEACH (COMBIPACK OF CLARITHROMYCIN 250MG | $50.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS LOKIT HP 20MG CAPSULES 20000 PACKS OF 7X6CAPS EACH (COMBIPACK OF CLARITHROMYCIN | $38.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS:CLARIMIN 500 MG TABS[1174PACKx10x1x10=117400TAB]CLARITHROMYCIN 500 MG AS PER INV | $30.4K | 2 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS:CLARIMIN 500 MG TABS1125PACKx10x1x10=112500TAB]CLARITHROMYCIN 500 MG AS PER INV | $29.1K | 2 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSAUSTELL CLARITHROMYCIN 500 MG TABLETS (EACH TABLET CONTAINES CLARITHROMYCIN 500 | $25.6K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS:CLARIMIN 500 MG TABS(1692PACKX10X1X10=169200 TAB)(CLARITHROMYCIN 500MG AS PER INV | $21.2K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS LOKIT HP 20MG CAPSULES 5016 PACKS OF 7X1X6 CAPS EACH (COMBIPACK OF CLARITHROMYCIN | $9.7K | 1 |
Kopran Limited exports 15 distinct Clarithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINE / PHARMACEUTICAL GOODSCLARITHROMYCINA 500 with 4 shipments worth $112.9K.
How Does Kopran Limited Compare to Nearest Clarithromycin Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | MEDICO REMEDIES LIMITED | $1.3M | 42 | 6 | $30.5K |
| 11 | MEDLEY PHARMACEUTICALS LIMITED | $1.1M | 22 | 2 | $50.0K |
| 14 | KOPRAN LIMITED ★ | $888.1K | 21 | 7 | $42.3K |
| 8 | LINCOLN PHARMACEUTICALS LTD | $850.0K | 17 | 3 | $50.0K |
| 15 | PROSFORA TECHNOLOGIES PRIVATE LIMITED | $300.0K | 6 | 1 | $50.0K |
Kopran Limited ranks #14 among 334 Indian Clarithromycin exporters. Average shipment value of $42.3K compared to the market average of $183.3K. The closest competitors by value are MEDICO REMEDIES LIMITED and MEDLEY PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Clarithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 365 | 10.2% |
| DELHI AIR CARGO ACC (INDEL4) | 296 | 8.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 282 | 7.9% |
| DELHI AIR | 258 | 7.2% |
| NHAVA SHEVA SEA (INNSA1) | 229 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 156 | 4.4% |
| JNPT | 125 | 3.5% |
| DHANNAD ICD | 124 | 3.5% |
About Kopran Limited
Kopran Limited exports 6 products worth $7.3M. Beyond Clarithromycin, top products include Kit, Enalapril, Flucloxacillin, Atenolol, Salmeterol. View the complete Kopran Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clarithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clarithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Kopran Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 21 individual customs records matching Kopran Limited exporting Clarithromycin, covering 15 formulations to 7 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 811+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clarithromycin Export Data from Kopran Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kopran Limited's Clarithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kopran Limited
Full Company Profile →
6 products · $7.3M total trade · 5 categories
Clarithromycin Stats
Company Overview
Top Products by Kopran Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Kopran Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clarithromycin. For current shipment-level data, contact TransData Nexus.